10 studies found for:    Lupus AND Los Angeles | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
Lupus AND Los Angeles | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Epratuzumab;   Drug: Placebo
2 Recruiting Vitamin D3 in Pediatric SLE
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Vitamin D3
3 Recruiting Functional MRI in Lupus Nephritis
Condition: Lupus Nephritis
Intervention:
4 Recruiting A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic;   Lupus Erythematosus, Discoid;   Healthy
Interventions: Procedure: Skin biopsy;   Procedure: Blood collection;   Procedure: Urine collection
5 Recruiting Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
6 Recruiting Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
7 Recruiting Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Placebo;   Drug: Epratuzumab
8 Recruiting Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Mycophenolate Mofetil;   Drug: Hydroxychloroquine or Chloroquine;   Drug: Prednisone
9 Recruiting Anti-Tweak in Lupus Nephritis Patients
Condition: Lupus Nephritis
Interventions: Biological: BIIB023;   Biological: Placebo
10 Recruiting A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Tabalumab Auto-Injector;   Drug: Tabalumab Prefilled Syringe

Indicates status has not been verified in more than two years